| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |